DPHARM® Announces First Slate of Keynotes for 15th Annual Event
The Conference Forum announced the first keynotes of the DPHARM®: Disruptive Innovations to Modernize Clinical Research conference, including the former heads of Merck and FDA, for the 2025 meeting.
"The 2025 keynotes were highly recommended by R&D executives on innovating for patients during an unprecedented flurry of changes, as clinical trial protocols continue to add to the levels of patient and site burden," said
"We are at a real moment of inflection and change in our industry. This year's lineup represents an incredible list of keynote speakers that have seen it all over the years and I'm excited to hear their expert thoughts on what happens next and how we can innovate our way through the challenges in front of us," said
The 2025 keynotes include:
"Our industry has always been shaped by waves of change – each one challenging, each one filled with possibility. I'm inspired to hear
In addition to the keynotes, DPHARM 2025 has over 200 speakers. The DPHARM agenda is carefully curated with the guidance of over 75 advisors representing pharmaceutical senior clinical operation executives, patient advocacy, clinical sites, innovative tech and service companies, academia and regulatory authorities.
DPHARM will be preceded by the Partnerships with Sites summit and the 10th annual CRAACO®: Clinical Research as a Care Option conference,
For the full DPHARM agenda, visit www.DPHARMconference.com.
About DPHARM:
DPHARM®: Disruptive Innovations to Modernize Clinical Research offers an unparalleled opportunity to hear senior clinical operations executives and innovative thought leaders report on innovations that are modernizing clinical trials and reducing patient burden. The concept of DPHARM was founded by Pfizer and Johnson & Johnson, who continue to play a key role on the steering committee to deliver a highly relevant and engaging program. DPHARM takes place
About The Conference Forum:
The Conference Forum is a life science industry research firm that develops conferences primarily around how to get therapeutics to patients faster. The company also publishes digital editorial across six categories, and produces PharmaTalkRadio, virtual events, and webinars.
View original content:https://www.prnewswire.com/news-releases/dpharm-announces-first-slate-of-keynotes-for-15th-annual-event-302478840.html
SOURCE DPHARM
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Colt DCS appoints David Burton as Chief Information Officer
- apg Solutions Appoints Wade Reitmeier as Vice President of Product & Engineering and Confirms Bart Hoemann as Vice President of Operations
- Share buybacks in Ericsson during the period June 29 - July 3, 2026
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share